Treatment of Chorioamnionitis After Delivery
NCT00814905 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2025-08-03
Summary
Chorioamnionitis occurs in 1% to 5% of term pregnancies and may complicate up to 25% of cases of preterm labor. The traditional regimen used to treat intra-amniotic infection is intravenous ampicillin 2g every 6 hours and intravenous gentamicin 1.5 mg/kg every 8 hrs until delivery . In the past the recommendation has been that the antibiotics be continued postpartum until 24-48 hours afebrile. More recent studies have looked at using a one time dose of antibiotics after delivery vs treating until 24-48 hours afebrile. There have been no studies comparing treatment of chorioamnionitis with antibiotics vs no treatment with antibiotics postpartum. The aim of this study is to compare no treatment vs treatment with one dose after a vaginal delivery and one dose of antibiotics vs a full course until 24 hours afebrile after a cesarean delivery complicated by chorioamnionitis. The hypothesis is that there will be no difference in outcome between the two groups in each arm. This is a randomized study. Once the patient delivers she will be randomized to one of two groups in each arm. First arm (vaginal delivery) A: no treatment, B: treatment with a one time dose of ampicillin/gentamicin; Second arm (c/s) A: one dose of ampicillin/gentamicin/clindamycin, B: treatment with ampicillin/gentamicin and clindamycin until 24 hours afebrile. The goal of the study is to determine the optimal postpartum management of chorioamnionitis.
Conditions
- Chorioamnionitis
Interventions
- DRUG
-
saline
A saline infusion after delivery (one dose)
- DRUG
-
ampicillin gentamicin
one additional dose of antibiotics (ampicillin 2 grams IV, gentamicin 1.5 mg/kg IV) following their vaginal delivery
- DRUG
-
Ampicillin gentamicin clindamycin
one dose of ampicillin 2 grams IV, gentamicin 1.5 mg/kg IV, clindamycin 900 mg IV and then saline infusions instead of antibiotics until they are afebrile for 24 hours ( they will receive saline infusions instead of antibiotics)
- DRUG
-
ampicillin gentamicin clindamycin
ampicillin 2 g IV every 6 hours, gentamicin 1.5mg/kg every 8 hours, and clindamycin 900 mg IV every 8 hours until the patient has been afebrile for 24 hours
Sponsors & Collaborators
-
United States Naval Medical Center, Portsmouth
lead FED
Principal Investigators
-
Everett F Magann, MD · Naval Officer, Naval Medical Center - Portsmouth
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-11-18
- Primary Completion
- 2012-01-31
- Completion
- 2012-09-30
Countries
- United States
Study Locations
More Related Trials
-
Azithromycin and Ampicillin for Late PPROM
NCT07183462 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome
NCT02477423 ·Status: COMPLETED ·Phase: NA
-
Treatment of Bacterial Vaginosis Prior to Active Labor and Infectious Morbidity
NCT03954990 ·Status: TERMINATED ·Phase: PHASE1
-
Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis
NCT00195923 ·Status: COMPLETED
-
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
NCT01503606 ·Status: COMPLETED ·Phase: PHASE3
-
Antibiotics Study in Preterm Premature Rupture of the Membranes
NCT01401179 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes
NCT07148622 ·Status: COMPLETED ·Phase: NA
-
Intrapartum Vancomycin for Group B Streptococcus (GBS) Prophylaxis
NCT02143154 ·Status: COMPLETED
-
Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
NCT00642980 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained Liquor
NCT01290003 ·Status: COMPLETED ·Phase: NA
-
NICU Antibiotics and Outcomes Trial
NCT03997266 ·Status: COMPLETED ·Phase: PHASE4
-
Population Pharmacokinetics of Amikacin in Neonates
NCT04867135 ·Status: COMPLETED
-
Non-operative Management of Pediatric Appendicitis With an Appendicoltih
NCT02189668 ·Status: TERMINATED ·Phase: NA
-
Oral Amoxicillin and Cephalexin PK/PD in Neonates
NCT04916951 ·Status: COMPLETED ·Phase: PHASE1
-
Procalcitonin Guided Antibiotic Therapy
NCT04240288 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy Study of Community-Based Treatment of Serious Bacterial Infections in Young Infants
NCT00189384 ·Status: UNKNOWN ·Phase: PHASE3
-
Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)
NCT05156437 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.
NCT04126031 ·Status: TERMINATED ·Phase: PHASE2
-
Oral Antibiotics After Obstetric Perineal Tear
NCT05830162 ·Status: COMPLETED ·Phase: PHASE4
-
New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea
NCT03294395 ·Status: COMPLETED ·Phase: PHASE3
-
Partial Oral Antibiotic Treatment for Bacterial Brain Abscess
NCT04140903 ·Status: RECRUITING ·Phase: PHASE4
-
Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis
NCT03289351 ·Status: COMPLETED ·Phase: PHASE4
-
Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth
NCT06349122 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Management of Early Onset Neonatal Septicaemia: Selection of Optimal Antibacterial Regimen for Empiric Treatment
NCT00487019 ·Status: COMPLETED